STAAB THOMAS R II
- SEC CIK
- 0001230708
Latest role at each company
- TENX TENAX THERAPEUTICS, INC.Chief Financial Officeras of Sep 15, 2026
- LNSR LENSAR, Inc.Chief Financial Officeras of May 8, 2026
Trades
Every Form 4 that lists STAAB THOMAS R II as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| TENXTENAX THERAPEUTICS, INC. | Sep 15, 20269:30 PM ET | Sep 11, 2026 | STAAB THOMAS R IIChief Financial Officer | PPurchaseCommon Stock | +5.68K | $1.935 | +$10.98K | 15.68K | +56.8% | SEC |
| LNSRLENSAR, Inc. | Dec 7, 2022 | Dec 6 – Dec 7, 2022 | STAAB THOMAS R IIChief Financial Officer | PPurchaseCommon Stock | +2.75K | $3.16 | +$8.7K | 135.13K | +2.1% | SEC |